• SmD2 Acetylation Rewires PARP Sensitivity in HCC

  2026-08-14

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon selection, DNA repair, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its preclinical data support testing SmD2–HDAC2–p300 biology as a biomarker-guided strategy for PARP inhibitor combinations in BRCA-proficient HCC.

• Fingolimod (FTY720) Research Workflows

  2026-08-14

  Build reproducible Fingolimod assays for lymphocyte trafficking, neuroprotection via BDNF upregulation, and immune-engineering controls. This workflow also shows how FTY720 can be used as a mechanistic comparator when evaluating magnetically guided CAR-T-mimicking cells, without assuming unproven combination benefit.

• 4-Phenylbutyric Acid: ER Stress Research Guide

  2026-08-13

  4-Phenylbutyric acid, also called 4-PBA, is a chemical chaperone used to study ER stress alleviation and protein-folding responses. In a liver cancer cell study, 4-PBA reduced cell death caused by capillarisenol C, supporting its use as a mechanistic rescue control rather than as a universal pathway-specific inhibitor.

• BAY-826 as a Causal Probe in Retinal Signaling

  2026-08-13

  BAY-826 is a potent small molecule inhibitor that can help dissect glia-mediated angiopoietin and PEDF signaling in retinal models. This article focuses on causal assay design, compartment-specific readouts, and the evidence limits that distinguish pathway perturbation from direct neuronal toxicity.

• H-89 for PKA and cAMP Signaling Workflows

  2026-08-12

  H-89 enables controlled protein kinase A inhibition in cAMP signaling, osteogenesis, metabolism, proliferation, and apoptosis assays. This practical guide translates the Wnt–PKA–O-GlcNAc mechanism into dose-conscious workflows, controls, and troubleshooting strategies.

• U 46619: From TP Signaling to Translation

  2026-08-12

  U 46619, also known as 11,9 epoxymethano-prostaglandin H2, offers translational researchers a defined way to interrogate TP-receptor biology across platelet activation, vascular tone, and renal hemodynamics. This thought-leadership guide connects concentration-dependent phenotypes with experimental design, clarifies how the tool differs from anticoagulant models such as dabigatran, and outlines a rigorous framework for moving from mechanistic assays to translational interpretation.

• Neticonazole Hydrochloride: Mechanisms & Uses

  2026-08-11

  Neticonazole Hydrochloride is an imidazole antifungal used in topical research and cutaneous candidiasis care. Product documentation also describes preclinical colorectal cancer research involving exosome inhibition in cancer and apoptosis induction via Bcl-2/Bax regulation, but these oncology findings are not clinical indications.

• Neticonazole Hydrochloride: From Diagnosis to Assays

  2026-08-10

  Neticonazole Hydrochloride is an imidazole antifungal with a distinctive evidence profile spanning cutaneous candidiasis and colorectal cancer research. This article presents an assay-first framework that separates validated clinical mycology decisions from emerging exosome and apoptosis studies.

• AZD1480: A Causal Probe of JAK2/STAT3

  2026-08-09

  AZD1480 is a potent JAK2 inhibitor for resolving how cytokine-driven STAT3 signaling protects tumor cells. This article presents an assay-centered framework that connects IDO1-inhibition biology with temporal pathway mapping, combination studies, and model-specific interpretation.

• FAISL Stabilizes FAK to Drive TNBC Metastasis

  2026-08-08

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby promoting adhesion, survival, proliferation, and metastasis in triple-negative breast cancer. Its combination of transcriptomic discovery, mechanistic protein analysis, functional assays, and nanoparticle-delivered siRNA provides a framework for targeting FAK regulation beyond kinase inhibition.

• BHQ in Calcium Signaling Research

  2026-08-07

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) provides an acute way to perturb SERCA-dependent calcium storage in live-cell, vascular, muscle, and stem-cell assays. This guide translates its mechanism into practical workflows, with emphasis on concentration planning, ER calcium readouts, HSC mobilization experiments, and troubleshooting.

• Cryo-EM Reveals αvβ3 Integrin Structural Dynamics and Drug T

  2026-08-07

  This study provides high-resolution cryo-EM structures of full-length human αvβ3 integrin, uncovering six apo and five ligand-bound conformations, including five previously uncharacterized intermediates and a novel tetrameric assembly. These findings significantly advance the structural understanding of integrin activation, offering a framework for the rational design of targeted therapeutics with greater selectivity and reduced off-target effects.

• Gefitinib (ZD1839): Beyond Oncology—A Tool for EGFR Pathway

  2026-08-06

  Explore the multifaceted applications of Gefitinib (ZD1839) as a precision EGFR inhibitor. This article uniquely bridges advanced cancer research with emerging insights into barrier function and photodamage models, offering scientists actionable protocols and deeper mechanistic clarity.

• Hematoxylin and Eosin Staining Kit: Protocols and QC Guidanc

  2026-08-06

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for consistent histopathological and cytological tissue staining, enabling clear visualization of cellular and tissue morphology in research settings. It should be used exclusively for scientific research, not for diagnostic or clinical applications, and is optimized for paraffin-embedded, frozen, or cytological samples.

• Zolmitriptan (SKU B2261): Reliable 5-HT1B Agonist for Migrai

  2026-08-05

  This article provides an in-depth, scenario-driven exploration of Zolmitriptan (SKU B2261) for cell-based migraine and cluster headache research. It addresses experimental design, solubility, protocol optimization, and vendor selection, highlighting validated workflow parameters and data-backed reliability. Researchers will discover how Zolmitriptan’s formulation and purity support reproducible, high-sensitivity assays.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page